Search Results - "Burroni, Barbara"

Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.

Authors: Bonnet, Sarah Carillo, Serge Legrand, Baptiste et al.

Source: European Journal of Haematology. Mar2024, Vol. 112 Issue 3, p475-478. 4p.

Listeria-Associated Lymphadenitis: A Series of 11 Consecutive Cases and Review of the Literature.

Authors: Blot, Mathieu Disson, Olivier Leclercq, Alexandre et al.

Source: Open Forum Infectious Diseases. Jan2022, Vol. 9 Issue 1, p1-6. 6p.

Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis.

Authors: Vigneron, Clara Le Stang, Valentine Decroocq, Justine et al.

Source: Acta Oncologica. May2022, Vol. 61 Issue 5, p608-610. 3p. 1 Chart, 1 Graph.

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma.

Authors: Saleh, Khalil Cheminant, Morgane Chiron, David et al.

Source: Cancers. Jul2022, Vol. 14 Issue 13, pN.PAG-N.PAG. 21p.

Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer.

Authors: Alifano, Marco Mansuet-Lupo, Audrey Lococo, Filippo et al.

Source: PLoS ONE. Sep2014, Vol. 9 Issue 9, p1-11. 11p.

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.

Authors: Damotte, Diane Warren, Sarah Arrondeau, Jennifer et al.

Source: Journal of Translational Medicine. 11/4/2019, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p.

The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphoma.

Authors: Grignano, Eric Laurent, Jérémy Deau, Bénédicte et al.

Source: European Journal of Haematology. Aug2018, Vol. 101 Issue 2, p150-159. 10p.